Theriva Biologics, Inc.
Q4 2025 13F Holders
Symbol
TOVX
CUSIP
87164U508
Type
Equity
Class
COM NEW
Num filings
21
Total reported value, excl. options
$272 k
Compare 2025 Q4 to
2026 Q2
2026 Q1
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type